Search The Defender
Search Results for "moderna"
08/23/22Moderna Rolls Out Untested ‘Bivalent’ Vaccine for COVID Strains No Longer Circulating
The U.K. last week became the first country to approve Moderna’s new bivalent COVID-19 booster containing mRNA that codes for the original Wuhan strain spike protein and the Omicron BA.1 subvariant — both of which are no longer in circulation.
08/10/22Did Pfizer, Moderna Skip Animal Trials? Fact-Checking the Fact-Checkers
As claims of COVID-19 vaccine makers skipping animal trials resurfaced and started trending again on social media, political commentator Kim Iversen “fact-checked the fact-checkers” in her latest episode of “The Kim Iversen Show.”
08/09/22Moderna Clinical Trials Terribly Flawed — and FDA Knew It, Former Pharma Executive Tells RFK Jr.
There were “terrible flaws” in Moderna’s COVID-19 vaccine clinical trials — and the U.S. Food and Drug Administration knew it, Alexandra (Sasha) Latypova told Robert F. Kennedy Jr., on a recent episode of “RFK Jr. The Defender Podcast.”
07/29/22U.S. Sets $1.74 Billion Deal With Moderna for Updated COVID Vaccine + More
The Defender’s COVID NewsWatch provides a roundup of the latest headlines related to the SARS CoV-2 virus, including its origins and COVID vaccines.
07/12/22FDA Colluded With Moderna to Bypass COVID Vaccine Safety Standards, Documents Reveal
According to Alexandra Latypova, an ex-pharmaceutical industry executive, documents obtained from the U.S. Department of Health and Human Services on Moderna’s COVID-19 vaccine suggest the U.S. Food and Drug Administration and Moderna colluded to bypass regulatory and scientific standards used to ensure products are safe.
06/29/22Pfizer, Moderna Shots More Likely to Cause Serious Injury Than Reduce Risk of COVID-Related Hospitalization
A new analysis of Pfizer and Moderna COVID-19 vaccine trial data shows the risk of serious injury following the vaccine is greater than the reduction in COVID-19 hospitalizations, according to a study posted June 23 on Social Science Research Network.
06/23/22Pfizer, Moderna COVID Vaccines May Increase Risk of Infection, Study Shows
A peer-reviewed study in the New England Journal of Medicine shows two doses of an mRNA COVID-19 vaccine yield negative protection against symptomatic SARS-CoV-2 infection, while previous infection without vaccination offers about 50% immunity.
06/23/22Nonprofit Sues FDA to Obtain Documents Related to Approval of Moderna Spikevax Vaccine
A nonprofit group is suing the U.S. Food and Drug Administration in an effort to obtain documents relating to the FDA’s approval of Moderna’s Spikevax COVID-19 vaccine after the agency told the group there was “no compelling need” to expedite the release of the documents.
06/16/22Moderna to Study Its COVID Vaccine in Babies as Young as 3 Months + More
The Defender’s COVID NewsWatch provides a roundup of the latest headlines related to the SARS CoV-2 virus, including its origins and COVID vaccines.
06/15/22FDA Advisors Unanimously Endorse Pfizer, Moderna COVID Shots for Infants and Young Kids, Ignore Pleas to ‘First Do No Harm’
“All the risks are to the innocent children and all of the billion-dollar rewards go to the government-protected pharmaceuticals,” said Rep. Louie Gohmert (R-Texas), after advisors to the U.S. Food and Drug Administration today voted 21-0 to recommend Pfizer’s and Moderna’s COVID-19 vaccines for infants and young children.
06/14/22Breaking: FDA Panel Recommends Moderna Two-Dose COVID Vaccine for Kids Ages 6 to 17 Despite Serious Safety Concerns
The U.S. Food and Drug Administration’s vaccine advisory panel on Tuesday voted 22 – 0 to authorize Moderna’s COVID-19 vaccines for children ages 6 to 11 and 12 to 17 despite the lack of short- and long-term safety data and no evidence children are at risk of serious illness.
06/14/22FDA Advisers Weigh Moderna COVID Vaccine Heart Risk for Young Men + More
The Defender’s COVID NewsWatch provides a roundup of the latest headlines related to the SARS CoV-2 virus, including its origins and COVID vaccines.
06/13/22FDA Risk-Benefit Analysis Hides ‘Bad Data’ on Moderna Shots for Kids
The U.S. Food and Drug Administration’s risk-benefit document in connection with the Moderna mRNA shot in kids is dishonest, and evidence that the public health establishment has abandoned science, logic, reason, rationality, empathy, health and medicine.
06/02/22Young Males Have Highest Risk of Heart Damage From Pfizer, Moderna Vaccines, Large Study Confirms
Young males are more likely to report heart damage following vaccination with an mRNA COVID-19 vaccine, and the damage is more likely to be reported after the second dose, according to researchers who reviewed the scientific literature and vaccine injury databases in the U.K., EU and U.S.
06/01/22Will FDA Allow Pfizer, Moderna to Skip Clinical Trials for Future COVID Vaccines?
The U.S. Food and Drug Administration’s vaccine advisory committee will vote June 28 on something called the “Future Framework,” a scheme that would allow Pfizer and Moderna to “reformulate” COVID-19 mRNA vaccines in perpetuity, without conducting clinical trials on the new vaccines.
05/26/22‘Nobody Wants Them’: Moderna Throwing out 30 Million Vaccine Doses, CEO Says + More
The Defender’s COVID NewsWatch provides a roundup of the latest headlines related to the SARS CoV-2 virus, including its origins and COVID vaccines.
05/23/22FDA Panel Sets June 15 Meeting on Pfizer, Moderna COVID Vaccines for Infants and Toddlers + More
The Defender’s COVID NewsWatch provides a roundup of the latest headlines related to the SARS CoV-2 virus, including its origins and COVID vaccines.
05/17/22Moderna Vaccine Delivered More Risk Than Benefit in Trials for Children 6 to 11, Despite New York Times Positive Spin
Moderna’s COVID-19 vaccine was “found to be safe and effective in inducing immune responses and preventing COVID-19,” according to an analysis of the results of the vaccine trials in children ages 6 to 11, but a closer look reveals the vaccine delivered more risk than benefit.
05/12/22Moderna Completes FDA Submission for Use of COVID Shot in Adolescents, Kids + More
The Defender’s COVID NewsWatch provides a roundup of the latest headlines related to the SARS CoV-2 virus, including its origins and COVID vaccines.
05/06/22FDA Limits Use of J&J Vaccine Over Blood Clotting Disorder, But Experts Say Pfizer, Moderna Shots Pose Similar Risk
The U.S. Food and Drug Administration on Thursday put strict limits on the use of Johnson & Johnson’s COVID-19 vaccine, citing the risk of a blood clotting condition, but experts say that Pfizer and Moderna pose similar risks.
05/04/22Did Moderna Trial Data Predict ‘Pandemic of the Vaccinated?’
A new study based on Moderna’s Phase 3 clinical trial data suggests recipients of Moderna’s COVID-19 vaccine may be more likely to suffer repeated infections, perhaps indefinitely.
04/28/22Moderna Asks FDA to Authorize COVID Vaccines for Kids Under 6, Changes Efficacy Claims to Meet Guidelines
Moderna today asked the U.S. Food and Drug Administration to authorize its COVID-19 vaccine for children under age 6. The company claimed its trials for the 6-month to 2-year age group showed the vaccine was 51% effective — only 1% above the requirement — after last month stating the product was only 43.7% effective.
04/21/22Moderna to File for EUA of COVID Shot for Very Young Kids by April End + More
The Defender’s COVID NewsWatch provides a roundup of the latest headlines related to the SARS CoV-2 virus, including its origins and COVID vaccines.
04/11/22Exclusive: Son Describes Mother’s Death After Moderna Shot
In an exclusive interview with The Defender, Jeffrey Beauchine said his mother, Carol, knew her Creutzfeldt-Jakob Disease was related to the Moderna shot. Watching her death was like “something you see out of a movie,” he said.
04/08/22Moderna Recalls Thousands of COVID Vaccine Doses in Europe + More
The Defender’s COVID NewsWatch provides a roundup of the latest headlines related to the SARS CoV-2 virus, including its origins and COVID vaccines.
04/01/22FDA Weighing Moderna Vax for Kids 6 and Under, But Experts Say Trials Inadequate
Moderna plans to seek authorization for its pediatric COVID-19 vaccine for kids 6 and under, but experts say the vaccine maker’s trials for the young age group raise too many questions.
03/29/22Why Didn’t Pfizer, Moderna Have to Meet All FDA Criteria for EUA Products?
The U.S. Food and Drug Administration sets the criteria vaccine makers are supposed to meet in order to obtain Emergency Use Authorization for their products. So why didn’t Pfizer and Moderna have to meet all of those criteria?
03/29/22FDA Authorizes Fourth Pfizer and Moderna COVID Vaccine Doses for 50 and Older + More
The Defender’s COVID NewsWatch provides a roundup of the latest headlines related to the SARS CoV-2 virus, including its origins and COVID vaccines.
03/23/22Moderna to Seek Authorization for COVID Shots for Kids Despite No Proven Efficacy Against Omicron
Moderna Wednesday announced it will soon request Emergency Use Authorization for its pediatric COVID vaccine. The company said the majority of COVID cases observed during its pediatric clinical trials were mild, making it impossible to detect the vaccine’s protective effect against the worst outcomes.
03/18/22483 More Deaths After COVID Vaccines Reported to VAERS, as Pfizer and Moderna Push for More Boosters
VAERS data released Friday by the Centers for Disease Control and Prevention included a total of 1,183,495 reports of adverse events from all age groups following COVID vaccines, including 25,641 deaths and 208,209 serious injuries between Dec. 14, 2020, and March 11, 2022.